| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.121 | 0 | 3.284 | 14.183 | 25.727 | 13.740 | 83.460 | 61.600 | 169.035 | 0 |
| Total Income - EUR | 28.121 | 0 | 3.284 | 14.183 | 25.727 | 13.740 | 83.460 | 61.600 | 169.035 | 0 |
| Total Expenses - EUR | 3.445 | 951 | 4.256 | 13.308 | 21.104 | 3.017 | 7.367 | 525 | 19.535 | 18.905 |
| Gross Profit/Loss - EUR | 24.676 | -951 | -972 | 875 | 4.623 | 10.724 | 76.093 | 61.075 | 149.501 | -18.905 |
| Net Profit/Loss - EUR | 23.833 | -951 | -1.071 | 449 | 3.852 | 10.336 | 73.872 | 59.227 | 147.844 | -18.905 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Globemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 16.539 | 16.172 | 17.911 | 68.131 | 55.504 |
| Current Assets | 50.108 | 17.626 | 6.406 | 12.055 | 15.551 | 8.916 | 80.490 | 78.855 | 116.861 | 102.748 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 39.170 | 389 | 1.029 | 5.097 | 10.537 | 5.187 | 92 | 75.594 | 73.461 | 73.118 |
| Cash | 10.939 | 17.236 | 5.377 | 6.957 | 5.014 | 3.730 | 80.398 | 3.260 | 43.400 | 29.630 |
| Shareholders Funds | 43.081 | 11.879 | 11.542 | 11.788 | 15.411 | 25.455 | 93.456 | 86.398 | 160.299 | 140.498 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.027 | 7.899 | 0 | 266 | 140 | 0 | 3.206 | 10.368 | 26.067 | 18.348 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Globemed S.r.l.